Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1353511-55-3

Post Buying Request

1353511-55-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1353511-55-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1353511-55-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,5,3,5,1 and 1 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1353511-55:
(9*1)+(8*3)+(7*5)+(6*3)+(5*5)+(4*1)+(3*1)+(2*5)+(1*5)=133
133 % 10 = 3
So 1353511-55-3 is a valid CAS Registry Number.

1353511-55-3Downstream Products

1353511-55-3Relevant articles and documents

Regiocontrolled functionalization of 2,3-dihalogenoimidazo[1,2-a]pyridines by Suzuki-Miyaura and Sonogashira cross-coupling reactions

Delaye,Pénichon,Allouchi,Enguehard-Gueiffier,Gueiffier

, p. 4199 - 4203 (2017)

An efficient method for regiocontrolled functionalization of 2,3-dihalogenoimidazo[1,2-a]pyridine was developed. This sequence allowed the selective introduction of aryl, heteroaryl, alkyl and alkynyl substituents at both 2- and 3-positions, by using Suzu

Efficient access to 2,3-diarylimidazo[1,2-a ]pyridines via a one-pot, ligand-free, palladium-catalyzed three-component reaction under microwave irradiation

Wang, Yuanxiang,Frett, Brendan,Li, Hong-Yu

supporting information, p. 3016 - 3019 (2014/06/23)

An expeditious one-pot, ligand-free, Pd(OAc)2-catalyzed, three-component reaction for the synthesis of 2,3-diarylimidazo[1,2-a]pyridines was developed under microwave irradiation. With the high availability of commercial reagents and great efficiency in expanding molecule diversity, this methodology is superior to the existing procedures for the synthesis of 2,3-diarylimidazo[1,2-a]pyridines analogues.

Synthesis and biological evaluation of 2,3-diarylimidazo[1,2-a]pyridines as antileishmanial agents

Marhadour, Sophie,Marchand, Pascal,Pagniez, Fabrice,Bazin, Marc-Antoine,Picot, Carine,Lozach, Olivier,Ruchaud, Sandrine,Antoine, Maud,Meijer, Laurent,Rachidi, Najma,Le Pape, Patrice

, p. 543 - 556 (2013/02/23)

A novel series of 2,3-diarylimidazo[1,2-a]pyridines was synthesized and evaluated for their antileishmanial activities. Four derivatives exhibited good activity against the promastigote and intracellular amastigote stages of Leishmania major, coupled with a low cytotoxicity against the HeLa human cell line. The impact of compound lipophilicity on antiparasitic activities was investigated by Log D comparison. Although LmCK1 could be the parasitic target for three compounds (13, 18, 21), the inhibition of another target is under study to explain the antileishmanial effect of the most promising compounds.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1353511-55-3